Cargando…

Direct-from-specimen microbial growth inhibition spectrums under antibiotic exposure and comparison to conventional antimicrobial susceptibility testing

Increasing global travel and changes in the environment may escalate the frequency of contact with a natural host carrying an infection and, therefore, increase our chances of encountering microorganisms previously unknown to humans. During an emergency, the etiology of infection may be unknown at t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jade, San, Su Su Soe, Kung, Amelia, Tomasek, Michael, Liu, Dakai, Rodgers, William, Gau, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849476/
https://www.ncbi.nlm.nih.gov/pubmed/35171945
http://dx.doi.org/10.1371/journal.pone.0263868
_version_ 1784652474220544000
author Chen, Jade
San, Su Su Soe
Kung, Amelia
Tomasek, Michael
Liu, Dakai
Rodgers, William
Gau, Vincent
author_facet Chen, Jade
San, Su Su Soe
Kung, Amelia
Tomasek, Michael
Liu, Dakai
Rodgers, William
Gau, Vincent
author_sort Chen, Jade
collection PubMed
description Increasing global travel and changes in the environment may escalate the frequency of contact with a natural host carrying an infection and, therefore, increase our chances of encountering microorganisms previously unknown to humans. During an emergency, the etiology of infection may be unknown at the time of patient treatment. The existing local or global Antimicrobial Stewardship Programs may not be fully prepared for emerging/re-emerging infectious disease outbreaks, especially if they are caused by an unknown organism, engineered bioterrorist attack, or rapidly evolving superbug. We demonstrate an antimicrobial efficacy profiling method that can be performed in hours directly from clinical urine specimens. The antimicrobial potency was determined by the level of microbial growth inhibition and compared to conventional antimicrobial susceptibility testing results. The oligonucleotide probe pairs on the sensors were designed to target Gram-negative bacteria, specifically Enterobacterales and Pseudomonas aeruginosa. A pilot study of 10 remnant clinical specimens from the Clinical Laboratory Improvement Amendments-certified labs of New York-Presbyterian Queens was conducted, and only one sample was not detected by the probes. The remaining nine samples agreed with reference AST methods (Vitek and broth microdilution), resulting in 100% categorical agreement. In a separate feasibility study, we evaluated a dual-kinetic response approach, in which we inoculated two antibiotic stripwells containing the same antimicrobial concentrations with clinical specimens at the original concentration (1x) and at a 10-fold dilution (0.1x) to cover a broader range of microbiological responses. The combined categorical susceptibility reporting of 12 contrived urine specimens was 100% for ciprofloxacin, gentamicin, and meropenem over a range of microbial loads from 10(5) to 10(8) CFU/mL.
format Online
Article
Text
id pubmed-8849476
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-88494762022-02-17 Direct-from-specimen microbial growth inhibition spectrums under antibiotic exposure and comparison to conventional antimicrobial susceptibility testing Chen, Jade San, Su Su Soe Kung, Amelia Tomasek, Michael Liu, Dakai Rodgers, William Gau, Vincent PLoS One Research Article Increasing global travel and changes in the environment may escalate the frequency of contact with a natural host carrying an infection and, therefore, increase our chances of encountering microorganisms previously unknown to humans. During an emergency, the etiology of infection may be unknown at the time of patient treatment. The existing local or global Antimicrobial Stewardship Programs may not be fully prepared for emerging/re-emerging infectious disease outbreaks, especially if they are caused by an unknown organism, engineered bioterrorist attack, or rapidly evolving superbug. We demonstrate an antimicrobial efficacy profiling method that can be performed in hours directly from clinical urine specimens. The antimicrobial potency was determined by the level of microbial growth inhibition and compared to conventional antimicrobial susceptibility testing results. The oligonucleotide probe pairs on the sensors were designed to target Gram-negative bacteria, specifically Enterobacterales and Pseudomonas aeruginosa. A pilot study of 10 remnant clinical specimens from the Clinical Laboratory Improvement Amendments-certified labs of New York-Presbyterian Queens was conducted, and only one sample was not detected by the probes. The remaining nine samples agreed with reference AST methods (Vitek and broth microdilution), resulting in 100% categorical agreement. In a separate feasibility study, we evaluated a dual-kinetic response approach, in which we inoculated two antibiotic stripwells containing the same antimicrobial concentrations with clinical specimens at the original concentration (1x) and at a 10-fold dilution (0.1x) to cover a broader range of microbiological responses. The combined categorical susceptibility reporting of 12 contrived urine specimens was 100% for ciprofloxacin, gentamicin, and meropenem over a range of microbial loads from 10(5) to 10(8) CFU/mL. Public Library of Science 2022-02-16 /pmc/articles/PMC8849476/ /pubmed/35171945 http://dx.doi.org/10.1371/journal.pone.0263868 Text en © 2022 Chen et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Chen, Jade
San, Su Su Soe
Kung, Amelia
Tomasek, Michael
Liu, Dakai
Rodgers, William
Gau, Vincent
Direct-from-specimen microbial growth inhibition spectrums under antibiotic exposure and comparison to conventional antimicrobial susceptibility testing
title Direct-from-specimen microbial growth inhibition spectrums under antibiotic exposure and comparison to conventional antimicrobial susceptibility testing
title_full Direct-from-specimen microbial growth inhibition spectrums under antibiotic exposure and comparison to conventional antimicrobial susceptibility testing
title_fullStr Direct-from-specimen microbial growth inhibition spectrums under antibiotic exposure and comparison to conventional antimicrobial susceptibility testing
title_full_unstemmed Direct-from-specimen microbial growth inhibition spectrums under antibiotic exposure and comparison to conventional antimicrobial susceptibility testing
title_short Direct-from-specimen microbial growth inhibition spectrums under antibiotic exposure and comparison to conventional antimicrobial susceptibility testing
title_sort direct-from-specimen microbial growth inhibition spectrums under antibiotic exposure and comparison to conventional antimicrobial susceptibility testing
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849476/
https://www.ncbi.nlm.nih.gov/pubmed/35171945
http://dx.doi.org/10.1371/journal.pone.0263868
work_keys_str_mv AT chenjade directfromspecimenmicrobialgrowthinhibitionspectrumsunderantibioticexposureandcomparisontoconventionalantimicrobialsusceptibilitytesting
AT sansususoe directfromspecimenmicrobialgrowthinhibitionspectrumsunderantibioticexposureandcomparisontoconventionalantimicrobialsusceptibilitytesting
AT kungamelia directfromspecimenmicrobialgrowthinhibitionspectrumsunderantibioticexposureandcomparisontoconventionalantimicrobialsusceptibilitytesting
AT tomasekmichael directfromspecimenmicrobialgrowthinhibitionspectrumsunderantibioticexposureandcomparisontoconventionalantimicrobialsusceptibilitytesting
AT liudakai directfromspecimenmicrobialgrowthinhibitionspectrumsunderantibioticexposureandcomparisontoconventionalantimicrobialsusceptibilitytesting
AT rodgerswilliam directfromspecimenmicrobialgrowthinhibitionspectrumsunderantibioticexposureandcomparisontoconventionalantimicrobialsusceptibilitytesting
AT gauvincent directfromspecimenmicrobialgrowthinhibitionspectrumsunderantibioticexposureandcomparisontoconventionalantimicrobialsusceptibilitytesting